Barclays »

Aileron Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Aileron Therapeutics (RNTX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7k 2.6k 1.04

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Aileron Therapeutics

Voss Capital
Cable Car Capital
ADAR1 Capital Management
Vanguard Capital Management
BIOS Capital Management
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Velan Capital Investment Management
Rima Management
Prosight Management
Bleichroeder
Boothbay Fund Management
Geode Capital Management
University of Texas Investment Management Company

View all funds holding Aileron Therapeutics